Priya Tiwari retweeted
#Vaping is not cool—it’s harmful, addictive and illegal in India. 🚭
Let’s empower our children & youth to make healthy choices and say NO to e-cigarettes and vapes.
Protecting young minds means building a #tobacco & #nicotine #free #generation.
#NashaMuktBharat
#TFYC4
Let’s vote people !
Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the ASCO Board. Visit asco.org/election to learn more about the candidates and place your vote!
38
Priya Tiwari retweeted
One more reason to take Delhi's smog seriously: WHO's cancer agency (IARC) classifies outdoor air pollution and particulate matter as Group 1 carcinogens, with sufficient evidence for lung cancer.
On severe AQI days, limit outdoor exposure, esp. for kids.
nitter.cf/ndtv/status/2122155077…
Delhi continues to battle poor air quality as thick smog blankets the city.
Which age group of children faces the greatest risk from pollution exposure?
Watch Dr Sanjeev Bagai speak to @snehamordani about the impact of toxic air on children's health and how parents can protect them.
@ShivaniSinghRna
Useful and intersting !
List of 12 Approvals given in breast cancer by @usfda from 1st May 2026 till 16 th November 2026. For quick summary. #BCSM #OncoWisdom @DrUddiGoswami @dr_yakupergun @OncBrothers
1
74
Priya Tiwari retweeted
Ooo, supportive care. Easy win for patients.
Looks like swapping olanzapine out for mirtazapine significantly reduces nausea. Relevant to every oncologist.
Randomized trial from India at #ESMO26. 120 chemo-naive patients starting highly emetogenic chemo, randomized 1:1. Both arms got fosaprepitant + palonosetron + dex. Fourth drug was mirtazapine 15 mg vs olanzapine 5 mg, days 1–4.
Mirtazapine vs olanzapine:
Acute 78.5% vs 56.4%, p=0.01
Delayed 52.3% vs 25.5%, p=0.003
Overall 46.2% vs 21.8%, p=0.005
Major differences
120 patients? Minimal risk? I'm sold. The day after the paper comes out, I'll swap.
@realbowtiedoc thoughts?
@OncoAlert @TheGutOncLab @Onco_Nexus
Easier to explain too!
PRABITAS: PIII biweekly vs conventional TAS-102 + bev in refractory mCRC 🇯🇵, presented at #ESMO26.
Yay for confirmation. But everyone should have been doing this since the OG publications (and certainly after @CathyEngMD published).
The SUNLIGHT schedule (TAS-102 days 1–5 and 8–12, bev days 1 and 15, every 28 days) works, but the neutropenia is savage at almost 50% G3-4 on SUNLIGHT.
PRABITAS has the same dose but spreads it out a littttttle more: TAS-102 days 1–5 + 15-19 and bev every 14 days. 970 patients, dosing at physician discretion. The primary endpoint was OS with an NI margin of 1.25.
OS 11.3 vs 10.3 mo, HR 0.93 (95% CI 0.80–1.08). Non-inferior, and the curves are the same.
Massive tox reduction, consistent with prior data.
This shouldn't surprise anyone. Cathy Eng's group published this schedule in 2025: 16% grade ≥3 neutropenia, no febrile neutropenia, no G-CSF. The Japanese phase 2 data go back to 2020.
Do we really always need randomized data to change practice? Do patients deserve to wait for 5+ years?
Asking for a friend.
@OncoAlert @TheGutOncLab @Onco_Nexus
22
Priya Tiwari retweeted
#ESMO26 starts tomorrow.
Once again, I'm sharing the table I share before every major congress.
ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS)
💥 Recommended thresholds for clinically meaningful benefit.
👇
Priya Tiwari retweeted
In 100% agreement
Exercise should be a prescribed
New @JACCJournals @ACCinTouch scientific statement
jacc.org/doi/10.1016/j.jacc.…
Priya Tiwari retweeted
தேவிக்கு ஓர் இசை அர்ப்பணம்
நவராத்திரி கொண்டாடத்தின் முதல் நாளில் குங்கும அபிஷேகத்தில் தேவி லிங்க பைரவி. ஈஷா யோக மையதத்தில் உள்ள சூரிய குண்டம் மண்டபத்தில் இசை மற்றும் நடன நிகழ்ச்சி உற்சாகமாக நடைபெற்றது. அதன் சிறு தொகுப்பு உங்களுக்காக!
#IshaNavratri #NavratriDay1
Priya Tiwari retweeted
ASCO’s decision to reduce the waiting period for members to access meeting content from 12 months to just 30 days is a significant step toward accelerating access to scientific knowledge.
Thank you, @ASCO !
Yayy!!
Still long way to go
Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved 100% coverage under India's National HPV Vaccination Campaign, with the country crossing the 80 lakh (8 million) dose milestone.
State-wise Progress Highlights
100% Coverage States: Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram.
Above 90% Coverage: Bihar, Andhra Pradesh, and Assam.
Above 85% Coverage: Karnataka.
Above 60% Coverage: Chhattisgarh, Sikkim, Kerala, Telangana, and Odisha.
Highest Total Vaccinations: Uttar Pradesh leads all states with over 22 lakh doses administered.
pib.gov.in/PressReleasePage.…
1
2
101
Priya Tiwari retweeted
🚨 Can carboplatin work in HRR-mutated mCRPC?
Our prospective phase II CIPHER trial evaluated single-agent carboplatin in men with metastatic castration-resistant prostate cancer harboring germline or somatic HRR alterations.
📊 39 patients treated
• PSA50 response: 41.0%
• Median rPFS: 4.53 months
• ORR: 32.3% among radiographically assessable patients
• Median duration of response: 6.93 months
🧬 Response varied by genotype:
• BRCA2: PSA50 63%
• BRCA1: 33%
• ATM: 22%
• PALB2: 100% (2/2)
An interesting exploratory signal:
Germline HRR alterations had higher PSA50 responses than somatic alterations: 62.5% vs 26.1%.
Take-home: Carboplatin showed meaningful activity in molecularly selected HRR-altered mCRPC, particularly in BRCA-associated disease, and may offer a pragmatic option where access to PARP inhibitors is limited.
📄 CIPHER | ESMO Open 2026
@ESMO_Open @oncoalert @ASCO
#ProstateCancer #mCRPC #PrecisionOncology #CIPHER
Priya Tiwari retweeted
Behind Varanasi’s vibrant lanes lies Gulabi Meenakari—a centuries-old craft preserved with dedication by local artisans.
Explore the stories and traditions that make India incredible.
Credit: maroofculmen (IG)
#IncredibleIndia #UttarPradesh #Varanasi #Art #Meenakari #Culture
Priya Tiwari retweeted
Explore Sarnath, India's 45th #UNESCO World Heritage Site, where Lord #Buddha delivered his first sermon and the Wheel of Dharma was set in motion.
Discover the Dhamek Stupa, commemorating the traditional site within the Deer Park where Lord Buddha delivered his first sermon; the Chaukhandi Stupa, commemorating his meeting with his first disciples; and the Dharmarajika Stupa, one of the earliest Buddhist stupas commissioned by Emperor Ashoka.
Experience the enduring legacy of one of the world's most sacred Buddhist sites.
#Sarnath #UNESCOWorldHeritage #BuddhistHeritage #VisitIndia #IncredibleIndia
Priya Tiwari retweeted
How two young Indians are converting discarded shoes into slippers for school children in need ! At the GreenSole Foundation, founders Shriyans Bhandari and Ramesh Dhami have made it their mission to give discarded footwear a second life. Their initiative has impacted the lives of over eight lakh people across India. Last year alone, 1,30,589 pairs of slippers and 95,357 school bags were distributed to children. Most shoes we throw away are made from a complex mix of rubber, plastics, foam, leather, and textiles, making them extremely difficult to recycle. Globally, nearly 20 billion pairs of shoes are produced every year ending up in landfills. Next time you think of throwing away a pair of shoes, donate them & be part of the solution. #sustainability greensolefoundation.com
Priya Tiwari retweeted
Applications are now open for the International Collaboration for Research methods Development in Oncology (CReDO) Workshop—a six-day residential oncology research protocol development workshop.
(1st–6th March 2027).
Application deadline: 31st July 2026.
I strongly encourage oncology residents, fellows and early-career faculty with an interest in clinical research to apply.
Don't be deterred by the listed fee—most selected participants receive ~90% fee support through external grants.
#CReDO @OncoDaily @cspramesh @OncBrothers @oncology_bg @SirohiBhawna
Priya Tiwari retweeted
🔥off the press🔥
Durvalumab with gemcitabine-based CTx in advanced BTC: primary results from the phase IIIb TOURMALINE study
doi.org/10.1016/j.jhep.2026.…
@JHepatology
👉Consistent efficacy & safety across 7 different chemo regimes
@myESMO @EASLnews @ILCAnews @curecc
Priya Tiwari retweeted
🆕editorial in press: PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block? @Al3ssandroRusso
doi.org/10.1016/j.annonc.202…
Very important
Adding RT to SOX after D2 gastrectomy failed to improve DFS or OS—another nail in the coffin for routine adjuvant radiotherapy.
jamanetwork.com/journals/jam…
2
1
161
Priya Tiwari retweeted
We have excellent webinar today on GU updates from ASCO 2026.
It was well attended by over 145 oncologist .
I thank all my faculty for taking time out from their busy schedules .
I learned a lot from this discussion. I hope it was useful for all those who attended it . #OncoWisdom
Thank you @sonpavde @gbanna74 @yekeduz_emre @DVAraujoMD
@VanitaNoronha @Priya1111 @DrUddiGoswami @OncBrothers @oncodaily











































